CNNC Accuray is a joint venture established on March 26, 2019, in the Dongli Development Zone of Tianjin, by CNNC High Energy (Tianjin) Equipment Co., Ltd., a wholly-owned subsidiary of China Tongfang Co., Ltd. (01763.HK), a subsidiary of CNNC, and Accuray Asia Ltd., a subsidiary of Accuray Inc. (NASDAQ: ARAY), a proven and reliable radiotherapy equipment manufacturer. The joint venture will provide system solutions for precision radiotherapy treatments for tumors, including R&D, production, and services in China. Since its establishment in March 2019, CNNC Accuray has been committed to its mission of “Innovative Technology, Born for Love,” rooted in China and committed to continuous innovation and development, empowering medical professionals to provide high-quality medical services to patients.